URS
DAWN

Utah Retirement Systems’s Day One Biopharmaceuticals DAWN Stock Holding History

Utah Retirement Systems’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-34,184
Closed -$612K – 964
2022
Q2 		$612K Sell
34,184
-6,368
-16% -$65.8K 0.01% 797
2022
Q1 		$402K Hold
40,552
– – 0.01% 856
2021
Q4 		$684K Buy
+40,552
New +$833K 0.01% 826

Other funds holding DAWN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Utah Retirement Systems's DAWN Position: Q3 2022 in Review

Utah Retirement Systems sold out of Day One Biopharmaceuticals (DAWN) in Q3 2022, closing a stake of 34,184 shares — an estimated $612K sold.

Utah Retirement Systems first reported a position in DAWN in Q4 2021 and held it in 3 quarters. The position peaked at $684K in Q4 2021. 93 funds tracked by Wall St. Rank hold DAWN as of Q3 2022.

  • Utah Retirement Systems reported no remaining Day One Biopharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Utah Retirement Systems sold 34,184 Day One Biopharmaceuticals shares in Q3 2022, an estimated $612K.
  • Utah Retirement Systems first reported a position in Day One Biopharmaceuticals in Q4 2021 and held it in 3 quarters.
  • Utah Retirement Systems's Day One Biopharmaceuticals position peaked at $684K in Q4 2021.
  • 93 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q3 2022.

Based on Utah Retirement Systems's 13F filing for Q3 2022, filed 14 Nov 2022.